Opioid Sparing Pain Management Techniques for Gender Affirming Surgery
Trial Summary
What is the purpose of this trial?
This study will compare the current standard-of-care pain treatment regimen options that are available to patients who undergo gender-affirming surgery. The purpose of this research is to determine if any of these options are more (versus less) effective than the others to manage surgery related pain, after surgery.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of this treatment for pain management in gender affirming surgery?
Research shows that ultrasound-guided pudendal nerve blocks can provide effective pain control in male patients undergoing urologic procedures, with most patients experiencing well-controlled pain postoperatively. Additionally, the transversus abdominis plane (TAP) block is effective for postoperative pain relief in abdominal surgeries, as it anesthetizes sensory nerves in the abdominal wall, providing safer and reliable analgesia.12345
Is ultrasound-guided nerve block safe for pain management in surgeries?
Ultrasound-guided nerve blocks, such as the transversus abdominis plane (TAP) block and pudendal nerve block, have been shown to be safe and effective for pain management in various surgical procedures. Studies indicate that these techniques can provide good pain control with minimal complications when performed with ultrasound guidance.12367
How does the treatment for opioid sparing pain management in gender affirming surgery differ from other treatments?
This treatment uses Pecs I and II nerve blocks, which are a type of regional anesthesia that targets specific nerves to reduce pain, potentially lowering the need for opioids. This approach is unique because it combines ultrasound guidance for precise delivery, making it safer and more effective in managing pain compared to traditional methods that rely heavily on opioids.2891011
Research Team
Maurice M Garcia, M.D., MAS
Principal Investigator
Cedars-Sinai Medical Center
Eligibility Criteria
This trial is for transgender individuals aged 18 or older who are undergoing gender-affirming surgeries with specific doctors. It's not for those with contraindications to study drugs, implanted pain devices, non-English speakers, or anyone unable to sense pain due to neurological deficits.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo gender-affirming surgery with various anesthetic techniques to manage peri-operative pain
Post-operative Care
Participants are monitored for pain management and opioid side effects, with inpatient stay averaging 7 days
Follow-up
Participants are monitored for safety, effectiveness, and satisfaction with pain management after discharge
Treatment Details
Interventions
- Bilateral spermatic cord block (Local Anesthetic)
- Bilateral ultrasound guided Transversus Abdominis Plane Block (Local Anesthetic)
- Bupivacaine (Local Anesthetic)
- Local anesthetic (Local Anesthetic)
- Pecs I & II Block (Local Anesthetic)
- Ultrasound guided Continuous Femoral Nerve Block (Local Anesthetic)
- Ultrasound guided Continuous Infraclavicular Brachial Plexus Block (Local Anesthetic)
- Ultrasound guided Pudendal Nerve Block (Local Anesthetic)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Cedars-Sinai Medical Center
Lead Sponsor